Tal Falick Michaeli1,2, Tamar Abu Said1, Stanislav Raskin1

  • 1Department of Radiation Oncology, Sharett Institute of Oncology Hadassah Medical Center, Jerusalem 91120, Israel.

Cancers
|November 27, 2025
PubMed
概括

基于知识的RapidPlan (RP) 计划显著改善了第三阶段非小细胞肺癌 (NSCLC) 患者的危险器官节省,减少了心脏和食道剂量. 肺部毒性仍然是一个问题,影响整体存活率.

相关概念视频